These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 7297915)

  • 1. Circulating immune complexes in patients with fulminant hepatic failure.
    Canalese J; Wyke RJ; Vergani D; Eddleston AL; Williams R
    Gut; 1981 Oct; 22(10):845-8. PubMed ID: 7297915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histological appearances in fulminant hepatic failure with reference to aetiology, time of survival and role of immunological processes.
    Goertz J; Williams R
    Digestion; 1973; 8(1):68-79. PubMed ID: 4776490
    [No Abstract]   [Full Text] [Related]  

  • 3. Bacteraemia in patients with fulminant hepatic failure.
    Wyke RJ; Canalese JC; Gimson AE; Williams R
    Liver; 1982 Mar; 2(1):45-52. PubMed ID: 7176837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific antibodies to halothane-induced liver antigens in halothane-associated hepatitis.
    Kenna JG; Neuberger J; Williams R
    Br J Anaesth; 1987 Oct; 59(10):1286-90. PubMed ID: 3676056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fulminant hepatic failure.
    Khan JM; Wright RA
    J Ky Med Assoc; 1983 Apr; 81(4):231-4. PubMed ID: 6842059
    [No Abstract]   [Full Text] [Related]  

  • 6. Fulminant hepatic failure: is it a preventable syndrome?
    Bernuau JR
    Acta Gastroenterol Belg; 1998; 61(2):149-50. PubMed ID: 9658596
    [No Abstract]   [Full Text] [Related]  

  • 7. Controlled trials of charcoal hemoperfusion and prognostic factors in fulminant hepatic failure.
    O'Grady JG; Gimson AE; O'Brien CJ; Pucknell A; Hughes RD; Williams R
    Gastroenterology; 1988 May; 94(5 Pt 1):1186-92. PubMed ID: 3280388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating immune complexes after repeated halothane anaesthesia.
    Williams BD; White N; Amlot PL; Slaney J; Toseland PA
    Br Med J; 1977 Jul; 2(6080):159-62. PubMed ID: 871824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis and management of fulminant hepatic failure.
    Kirsh BM; Lam N; Layden TJ; Wiley TE
    Compr Ther; 1995 Apr; 21(4):166-71. PubMed ID: 7796572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early indicators of prognosis in fulminant hepatic failure.
    O'Grady JG; Alexander GJ; Hayllar KM; Williams R
    Gastroenterology; 1989 Aug; 97(2):439-45. PubMed ID: 2490426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibronectin and Kupffer cell function in fulminant hepatic failure.
    Imawari M; Hughes RD; Gove CD; Williams R
    Dig Dis Sci; 1985 Nov; 30(11):1028-33. PubMed ID: 4053913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Physiopathology and therapy of fulminant hepatitis].
    Sato S; Suzuki K; Takikawa Y
    Nihon Naika Gakkai Zasshi; 1999 Sep; 88(9):1783-8. PubMed ID: 10581764
    [No Abstract]   [Full Text] [Related]  

  • 13. [Focus: fulminant and subfulminant hepatic insufficiency].
    Fellay M; Kehtari R
    Rev Med Suisse Romande; 1996 Jun; 116(6):483-91. PubMed ID: 8711300
    [No Abstract]   [Full Text] [Related]  

  • 14. Intravenous acetylcysteine in paracetamol induced fulminant hepatic failure: a prospective controlled trial.
    Keays R; Harrison PM; Wendon JA; Forbes A; Gove C; Alexander GJ; Williams R
    BMJ; 1991 Oct; 303(6809):1026-9. PubMed ID: 1954453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fulminant and subfulminant liver failure: definitions and causes.
    Bernuau J; Rueff B; Benhamou JP
    Semin Liver Dis; 1986 May; 6(2):97-106. PubMed ID: 3529410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Substantial hepatic necrosis is prognostic in fulminant liver failure.
    Ndekwe P; Ghabril MS; Zang Y; Mann SA; Cummings OW; Lin J
    World J Gastroenterol; 2017 Jun; 23(23):4303-4310. PubMed ID: 28694671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating immune complexes and serum complement in Nigerian patients with non-A, non B hepatitis.
    Ayoola EA
    East Afr Med J; 1984 Oct; 61(10):752-6. PubMed ID: 6442978
    [No Abstract]   [Full Text] [Related]  

  • 18. Frequency of renal impairment in paracetamol overdose compared with other causes of acute liver damage.
    Wilkinson SP; Moodie H; Arroyo VA; Williams R
    J Clin Pathol; 1977 Feb; 30(2):141-3. PubMed ID: 845262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coagulation factor V and VIII/V ratio as predictors of outcome in paracetamol induced fulminant hepatic failure: relation to other prognostic indicators.
    Pereira LM; Langley PG; Hayllar KM; Tredger JM; Williams R
    Gut; 1992 Jan; 33(1):98-102. PubMed ID: 1740285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fulminant hepatic failure in childhood: an analysis of 31 cases.
    Psacharopoulos HT; Mowat AP; Davies M; Portmann B; Silk DB; Williams R
    Arch Dis Child; 1980 Apr; 55(4):252-8. PubMed ID: 7416773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.